Description: The percentage of women 16–24 years of age who were identified as sexually active and who had at least one test for
chlamydia during the measurement year.
||Commercial, Medicaid (report each product line separately).
||Women 16–24 years as of December 31 of the measurement year. Report two age stratifications and a total rate:
||The measurement year.
||No more than one gap in enrollment of up to 45 days during the measurement year. To determine continuous enrollment for a Medicaid beneficiary for whom enrollment is verified monthly, the member may not have more than a 1-month gap in coverage (i.e., a member whose coverage lapses for 2 months [60 days] is not considered continuously enrolled).
||December 31 of the measurement year.
Sexually active. Two methods identify sexually active women: pharmacy data and claim/encounter data. The organization must use both methods to identify the eligible population; however, a member only needs to be identified in one method to be eligible for the measure.
Claim/encounter data. Members who had a claim or encounter indicating sexual activity during the measurement year. A code from any of the following meets criteria:
Denominator Exclusions (when applicable): Note: Members in hospice are excluded from the eligible population. Refer to General
Guideline 20: Members in Hospice. Exclude members who qualified for the denominator based on a pregnancy test (Pregnancy Tests Value Set)
alone and who meet either of the following:
- A pregnancy test (Pregnancy Test Exclusion Value Set) during the measurement year and a prescription for isotretinoin (Table CHL-E)
on the date of the pregnancy test or the 6 days after the pregnancy test.
- A pregnancy test (Pregnancy Test Exclusion Value Set) during the measurement year and an x-ray (Diagnostic Radiology Value Set) on the date
of the pregnancy test or the 6 days after the pregnancy test.
|At least one chlamydia test (Chlamydia Tests Value Set) during the measurement year.|